Publication of results of a clinical trial. We confirmed that our original schedule of application of gemcitabine in low-dose (not more than 20% of the usual dose) in prolonged infusion leads to at least equal, and possibly better (for squamous carcinoma) results when compared to standard high-dose application in brief infusion
COBISS.SI-ID: 805243
Chapter in a multi-author volume (20 pages)
COBISS.SI-ID: 757627
Publication of a clinical trial. Treatment with low-dose gemcitabine in prolonged infusion and cisplatin was significantly superior to high-dose gemcitabine
COBISS.SI-ID: 968315
Scientific basis for intermittent therapy, based on differences in cell kinetics
COBISS.SI-ID: 1013115
Report on results of a clinical trial
COBISS.SI-ID: 000000000